Congenital Adrenal Hyperplasia Treatment Panel
Also known as: CAH RX PANEL
Use
The Congenital Adrenal Hyperplasia Treatment Panel is used for monitoring the treatment of individuals with classic or nonclassic congenital adrenal hyperplasia. By measuring specific hormones such as testosterone, 17-hydroxyprogesterone, and androstenedione, clinicians can assess the efficacy of treatment and adjust therapies accordingly to manage the conditions effectively.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration but is performed in a CLIA certified laboratory and is intended for clinical purposes. Measurements such as free or bioavailable testosterone can provide supportive information but are not part of this panel. Users should be aware that results should be interpreted within the context of the individual's clinical condition and other laboratory findings. Disruptions in the transport or handling of specimens outside the stated stability conditions might affect the accuracy of the results.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 1668-3 - 17OHP SerPl-mCnc
- 1854-9 - Androst SerPl-mCnc
- 2986-8 - Testost SerPl-mCnc
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.2 mL
Minimum Volume
0.7 mL
Container
Serum separator tube or green (sodium or lithium heparin) tube
Patient Preparation
Collect between 6-10 a.m.
Storage Instructions
Refrigerated storage required during transport.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 1 week |
| Frozen | 6 months |
Other tests from different labs that may be relevant